• Title/Summary/Keyword: The Graduate

Search Result 54,598, Processing Time 0.092 seconds

Algorithm of an automated auditory brainstem response neonatal hearing screening method (신생아를 대상으로한 청성뇌간유발반응의 자동 판독 알고리즘)

  • Jung, Won-Hyuk;Hong, Hyun-Ki;Kim, Sung-Woo;Kim, Jin-Tae;Park, Joong-Hoon;Kim, Deok-Won
    • Proceedings of the IEEK Conference
    • /
    • 2006.06a
    • /
    • pp.825-826
    • /
    • 2006

  • In this paper, we propose an algorithm that applies Rolle's theorem to automatically detect and label peak III and V of the normal, suprathreshold auditory brainstem response (ABR). ABR waveform were recorded from 55 normal-hearing ears at screening levels varying from 30 to 60 dBnHL. For each ABR waveform, the peak-finding algorithm proceeded in fourth steps: (1) Select maximum and minimum values of the target ABR waveform, (2) divide this range into n equal parts, (3) effective candidate peaks in the ABR waveform are identified using Rolle's theorem (4) peak III and V are identified from these candidate peaks based on their latency and morphology. As a result, proposed auto dectection method showed high correlation and accuracy with manual detection method performed by clinician. By using proposed algorithm, clinician can detect and label peak III and V faster and more efficient than manual detection method.

  • PDF

Impact of sarcopenia on biliary drainage during neoadjuvant therapy for pancreatic cancer

  • Kunio Kataoka;Eizaburo Ohno;Takuya Ishikawa;Kentaro Yamao;Yasuyuki Mizutani;Tadashi Iida;Hideki Takami;Osamu Maeda;Junpei Yamaguchi;Yukihiro Yokoyama;Tomoki Ebata;Yasuhiro Kodera;Hiroki Kawashima
    • Clinical Endoscopy
    • /
    • v.57 no.1
    • /
    • pp.112-121
    • /
    • 2024

  • Background/Aims: Since the usefulness of neoadjuvant chemo(radiation) therapy (NAT) for pancreatic cancer has been demonstrated, recurrent biliary obstruction (RBO) in patients with pancreatic cancer with a fully covered self-expandable metal stent (FCSEMS) during NAT is expected to increase. This study investigated the impact of sarcopenia on RBO in this setting. Methods: Patients were divided into normal and low skeletal muscle index (SMI) groups and retrospectively analyzed. Patient characteristics, overall survival, time to RBO (TRBO), stent-related adverse events, and postoperative complications were compared between the two groups. A Cox proportional hazard model was used to identify the risk factors for short TRBO. Results: A few significant differences were observed in patient characteristics, overall survival, stent-related adverse events, and postoperative complications between 38 patients in the normal SMI group and 17 in the low SMI group. The median TRBO was not reached in the normal SMI group and was 112 days in the low SMI group (p=0.004). In multivariate analysis, low SMI was the only risk factor for short TRBO, with a hazard ratio of 5.707 (95% confidence interval, 1.148-28.381; p=0.033). Conclusions: Sarcopenia was identified as an independent risk factor for RBO in patients with pancreatic cancer with FCSEMS during NAT.

  • https://doi.org/10.5946/ce.2022.278 인용 PDF